Postmarketing Surveillance Study With MOBEC®
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
- Status
- TERMINATED
- Phase
- PHASE3
A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE3
WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE3
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis
- Status
- COMPLETED
- Phase
- PHASE3
Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1